Pfizer Aktie
WKN: 852009 / ISIN: US7170811035
27.10.2014 13:15:24
|
Pfizer To Discontinue Development Of Remoxy Extended-Release Capsules CII
(RTTNews) - Pfizer Inc. (PFE) Monday said it has decided to discontinue its agreement with Pain Therapeutics, Inc. (PTIE), for developing and commercializing REMOXY Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone.
The company said it will return all rights, including responsibility for regulatory activities to Pain Therapeutics.
For the next six months, until the scheduled termination date, Pfizer will continue ongoing activities as per the agreement.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
Analysen zu Pfizer Inc.mehr Analysen
07.03.25 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.02.25 | Pfizer Kaufen | DZ BANK | |
05.02.25 | Pfizer Buy | Goldman Sachs Group Inc. | |
05.02.25 | Pfizer Neutral | UBS AG | |
05.02.25 | Pfizer Neutral | JP Morgan Chase & Co. |
Aktien in diesem Artikel
Pfizer Inc. | 23,19 | -0,06% |
|